PRO*MDD Study Protocol: Effectiveness of Outpatient Treatment Programs for Major Depressive Disorder: Metacognitive Therapy vs. Behavioral Activation a Single-Center Randomized Clinical Trial
Overview
This study protocol outlines a randomized clinical trial comparing Metacognitive Therapy and Behavioral Activation for Major Depressive Disorder in an outpatient setting. The research involves 128 patients assigned to either treatment modality, with assessments conducted over a period of up to 30 months. The primary focus is on measuring reductions in depression severity, while secondary outcomes include quality of life and psychosocial functioning.
- ID
08ca366efc084999- Source org
- OpenAlex
- Author
- Not recorded
- Published
- Not recorded
- OA status
- Not recorded
- DOI
- 10.3389/fpsyt.2018.00584
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- Not recorded
Tags
Verification
- identityok via crossref · score 1 · checked_at unknown
- legitimacykeep via unknown · score 1 · checked_at unknown
- linkok via http-check · 2026-07-28T03:58:44.050956+00:00
Cite this entry
BibTeX
@article{allodium:08ca366efc084999,
title = {PRO*MDD Study Protocol: Effectiveness of Outpatient Treatment Programs for Major Depressive Disorder: Metacognitive Therapy vs. Behavioral Activation a Single-Center Randomized Clinical Trial},
journal = {OpenAlex},
doi = {10.3389/fpsyt.2018.00584},
url = {https://doi.org/10.3389/fpsyt.2018.00584}
}RIS
TY - JOUR TI - PRO*MDD Study Protocol: Effectiveness of Outpatient Treatment Programs for Major Depressive Disorder: Metacognitive Therapy vs. Behavioral Activation a Single-Center Randomized Clinical Trial PB - OpenAlex DO - 10.3389/fpsyt.2018.00584 UR - https://doi.org/10.3389/fpsyt.2018.00584 ER -
APA
PRO*MDD Study Protocol: Effectiveness of Outpatient Treatment Programs for Major Depressive Disorder: Metacognitive Therapy vs. Behavioral Activation a Single-Center Randomized Clinical Trial. (n.d.). OpenAlex. https://doi.org/10.3389/fpsyt.2018.00584
Related entries
- Metacognitive Therapy for Depression in Adults: A Waiting List Randomized Controlled Trial with Six Months Follow-Up
- Metacognitive Therapy versus Cognitive Behaviour Therapy in Adults with Major Depression: A Parallel Single-Blind Randomised Trial
- Generic Group Metacognitive Therapy for Patients with Major Depressive Disorder and Related Problems: a Preliminary Evaluation in Specialized Mental Health Care
- The effect of metacognitive therapy on depressive symptoms from a transdiagnostic perspective: a systematic review, meta-regression and meta-analysis
- Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial
- Generic group metacognitive therapy for depression in specialized mental health care: an open trial with 6- and 12-month follow-ups
- Metacognitive Therapy for Depression Reduces Interpersonal Problems: Results From a Randomized Controlled Trial
- A Comparison of Metacognitive Therapy in Current Versus Persistent Depressive Disorder – A Pilot Outpatient Study
- A Randomized Controlled Trial of Metacognitive Therapy for Depression: Analysis of 1-Year Follow-Up
- Cognitive and Metacognitive Mechanisms of Change in Metacognitive Training for Depression